Nanobac Pharmaceuticals, Inc. Merger Partner, Eureka Genomics, and Glycos Biotechnologies, Inc. Work Together to Sequence Proprietary Bacterium to Support Emerging Biorefinery Industry
4/23/2009 1:26:32 PM
More...
|
Nanobac Pharmaceuticals, Inc. and Eureka Genomics Sign Merger Agreement
4/13/2009 10:43:55 AM
More...
|
Nanobac Pharmaceuticals, Inc. and Eureka Genomics Agree to Terms for Merger
3/17/2009 7:52:58 AM
More...
|
Nanobac Pharmaceuticals, Inc. Message to Shareholders
3/2/2009 11:39:44 AM
More...
|
Nanobac Pharmaceuticals, Inc. Message to Shareholders
2/27/2009 1:44:32 PM
More...
|
Nanobac Pharmaceuticals, Inc. Announces Publication of Association of Nanoparticle and Kidney Stone Formation
2/19/2008 10:02:34 AM
More...
|
Nanobac Pharmaceuticals, Inc. Engages Legal Team to Enforce Patent Rights
2/7/2008 8:47:03 AM
More...
|
Nanobac Pharmaceuticals, Inc. Signs LOI for the Acquisition of DNAPrint Genomics Inc. (DNAP)
2/1/2008 10:52:31 AM
More...
|
Nanobac Pharmaceuticals, Inc. Announces European Heart Journal Publication of Association Between Calcifying Nanoparticles and Aortic Stenosis
1/22/2008 9:24:36 AM
More...
|
Nanobac Pharmaceuticals, Inc. Announces NB2 Test for Calcified Nano Particles Now Available
10/23/2007 8:41:45 AM
More...
|
|